{"id":"W2899466366","doi":"10.1007/s40273-018-0732-4","title":"Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Midostaurin; Medicine; Cytarabine; Daunorubicin; Quality-adjusted life year; Internal medicine; Myeloid leukemia; Placebo; Oncology; Cost effectiveness; Leukemia; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001442864,0.0002530834,0.0005622091,0.0004295493,0.00005024437,0.00002102873,0.0004631783,0.00008666143,0.00008215502],"category_scores_gemma":[0.00006639265,0.000156975,0.0001180558,0.0007446987,0.0003946699,0.00009731946,0.00004652275,0.0002995065,0.00003364846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001869778,"about_ca_system_score_gemma":0.0005828571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005071077,"about_ca_topic_score_gemma":0.0003168258,"domain_scores_codex":[0.9977458,0.0007500434,0.0005726032,0.0003107663,0.0001896725,0.0004311215],"domain_scores_gemma":[0.9968871,0.00221632,0.0001820884,0.0004968925,0.0001366386,0.00008096809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06069352,0.009932617,0.3075264,0.002079078,0.005036152,0.002701375,0.1642023,0.02283207,0.3148164,0.001066724,0.01055969,0.09855361],"study_design_scores_gemma":[0.05859732,0.004903118,0.1687926,0.0003022996,0.0006611714,0.0001367037,0.008014807,0.06762555,0.6618998,0.0004175815,0.02809709,0.0005519345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959766,0.0001651533,0.00002850194,0.0008482043,0.00009630046,0.002318615,0.0001414774,0.00001521944,0.0004099154],"genre_scores_gemma":[0.9946492,0.003780717,0.00008583129,0.000692935,0.0001087457,0.0002827323,0.0003362961,0.0000346525,0.00002888261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3470834,"threshold_uncertainty_score":0.7665985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04306016700287379,"score_gpt":0.3720493581454838,"score_spread":0.32898919114261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}